EW - Edwards Lifesciences - Stock & Dividends

Edwards Lifesciences Corporation is a leading medical technology company that develops and manufactures innovative products for structural heart disease and critical care monitoring. The company's portfolio includes a range of transcatheter heart valve replacement and repair products, designed for minimally invasive procedures, under the Edwards SAPIEN family of valves system and PASCAL PRECISION and Cardioband names. These products are used to treat aortic, mitral, and tricuspid valve diseases, offering patients a less invasive alternative to traditional open-heart surgery.

In addition to its transcatheter solutions, Edwards Lifesciences also provides surgical structural heart solutions, including aortic surgical valves under the INSPIRIS name, which features RESILIA tissue and VFit technology. The company's surgical portfolio also includes the KONECT RESILIA pre-assembled tissue valves conduit for complex combined procedures and the MITRIS RESILIA valve. These products are designed to improve patient outcomes and provide surgeons with advanced tools for complex heart procedures.

Edwards Lifesciences' critical care solutions focus on hemodynamic monitoring systems, which provide clinicians with real-time data on a patient's heart function and fluid status in surgical and intensive care settings. The company's product offerings in this area include the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight systems, as well as the HemoSphere monitoring platform, which displays physiological information in a user-friendly format. The Acumen Hypotension Prediction Index software is also part of the company's critical care portfolio, providing clinicians with early warnings of potential hypotension events.

The company's products are distributed through a combination of direct sales force and independent distributors, allowing Edwards Lifesciences to reach a broad customer base globally. With a rich history dating back to 1958, the company is headquartered in Irvine, California, and continues to innovate and expand its product offerings to address the evolving needs of patients and clinicians worldwide.